*
*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients.
*
5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice
54321
Properly diagnose and manage primary and metastatic brain tumors
Apply targeted agents, immunotherapy and novel technologies to treat gliomas
*
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied
54321
Everybody Needs Prozac - Erik P. Sulman, M.D., Ph.D.
RAGE inhibitors for Gliomas - Jiayi Huang, M.D.
Low Intensity Focused Ultrasound - Michael McDermott, M.D.
ONC201 updates for H3 K27M mutant gliomas- Yazmin Odia, M.D.
Advances in the Management of Primary Brain Tumors - Moderator: Michael McDermott, M.D.
Supramaximal surgery for GBM - Shawn Hervey-Jumper, M.D.
Immunotherapy no more for GBM? -Andrew Lassman, M.D.
5ALA as a Therapeutic Agent - Walter Stummer, M.D.
Vaccine Updates for Gliomas - Manmeet Ahluwalia, M.D.
Brachytherapy vs SRS for Recurrent Brain Metastasis - Nelson Moss, M.D. vs. Steve Braunstein, M.D., Ph.D.
INDIGO: Go or No Go? - Andrew Lassman, M.D. vs. Robert Press, M.D.
Updates on TTFields Therapy - Rupesh Kotecha, M.D.
Metabolic Imaging for Brain Tumors - Susan Chang, M.D.
Management of Skull Base Chordoma and Chondrosarcoma - Shannon MacDonald, M.D.
Pediatric Cranial Radiosurgery - Erin Murphy, M.D.
*
*
*
*
*
*
*
*